Camp4 Therapeutics (CAMP) Revenue (2023 - 2026)

Camp4 Therapeutics recorded quarterly Revenue of $1.3 million in Q1 2026, up 271.84% quarter-over-quarter from $348000.0 in Q4 2025, and up 50.82% year-over-year from $858000.0 in Q1 2025.

Camp4 Therapeutics' Revenue history runs 4 years deep, the most recent figure standing at $1.3 million for Q1 2026.

  • In Q1 2026, Revenue rose 50.82% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $3.9 million (up 160.53% YoY), while the FY2025 annual figure was $3.5 million, up 436.5% from the prior year.
  • Revenue came in at $1.3 million for Q1 2026 at Camp4 Therapeutics, up from $348000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $1.5 million in Q2 2025 to a low of $348000.0 in Q4 2025.
  • A 4-year average of $827714.3 and a median of $795000.0 in 2025 frame the typical range for Revenue.
  • Across the five-year window, Revenue sank 46.63% in 2025 and jumped 50.82% in 2026, its largest moves.
  • Camp4 Therapeutics' Revenue stood at $350000.0 in 2023, then soared by 86.29% to $652000.0 in 2024, then tumbled by 46.63% to $348000.0 in 2025, then surged by 271.84% to $1.3 million in 2026.
  • According to Business Quant data, Revenue over the past three periods registered $1.3 million, $348000.0, and $795000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 306.30 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 2.99 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 3.61 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.17 Bn
10 Camp4 Therapeutics 245.89 Mn 245.89 Mn - 1.29 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.29 Mn
Dec 31, 2025 348,000.00
Sep 30, 2025 795,000.00
Jun 30, 2025 1.50 Mn
Mar 31, 2025 858,000.00
Dec 31, 2024 652,000.00
Sep 30, 2023 350,000.00